VIR

8.3905.41%
LC

Lawrence Corey

Co-founder & Head of Scientific Advisory Board

Dr. Lawrence Corey, also known as Larry, M.D., is Co-Principal Investigator of HVTN Leadership & Operations Center of HIV Vaccine Trials Network. Dr. Corey is Co-founder and Scientific Advisor of CERo Therapeutics Holdings, Inc. and serves as its Head of Scientific Advisory Board. Dr. Corey is Co-Founder and Head of Scientific Advisory Board of CERo Therapeutics, Inc. He serves as an Independent Director of Gritstone bio, Inc. since August 12 2022. He co-founded Vir Biotechnology, Inc. in 2016 and serves as its Scientific Advisor. Dr. Corey is a Co-Founder of Juno Therapeutics, Inc. and serves as its Senior Scientific Advisor. He is the Principal Clinical Investigator of the HIV Vaccine Trials Network (HVTN) of the National Institute of Allergy and Infectious Diseases (NIAID). He serves as Professor of Medicine and Laboratory Medicine and the Lawrence Corey Endowed Chair in Medical Virology at the University of Washington. Dr. Corey is an internationally-renowned expert in virology, T cell immunology and vaccine development. His research focuses on the immunology of herpes viruses, HIV and infections related to cancer and he is known for his expertise in translational medicine, clinical trial design and drug development. He was Executive Director at CERo Therapeutics Holdings, Inc. (formerly known as CERo Therapeutics, Inc.) Dr. Corey served as the President and Director of Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center from January 1, 2011 to November 2014. He has extensive experience with the development of experimental vaccines for both genital herpes and HIV. He served as the Joint Head of the Fred Hutchinson Cancer Research Center Clinical Research Division's Program in Infectious Diseases and the Virology Division of the University of Washington's Department of Laboratory Medicine. Dr. Corey served as the Chairman of Scientific Advisory Board at Immune Design Corp. Dr. Corey serves as a Member of Scientific Advisory Board at Immune Design Corp. and Agenovir Corporation. He serves as a Member of the Scientific Advisory Board of GenPhar, Incorporated. He serves as Director Emeritus of Fred Hutchinson Cancer Research Center. Dr. Corey is a Member of the editorial Board for the New England Journal of Medicine. He served as a Director of Juno Therapeutics, Inc. He served as a Director of Seattle Cancer Care Alliance. He served as Member of Advisory Board at Implicit Bioscience Limited. He specializes in herpes viruses, HIV and other infectious disease-related research, especially viral infections. Dr. Corey is an attending physician in Internal Medicine and Infectious Disease at the University of Washington affiliated hospitals. He is a Member of numerous committees and editorial boards in areas of infectious diseases, HIV infection and HIV vaccines. Dr. Corey's honors and awards include election to the American Academy of Arts and Sciences and the National Academy of Medicine branch of the National Academy of Sciences. He is a fellow of the Infectious Diseases Society of America and is a Member of the American Society for Clinical Investigation, American Epidemiological Society and Association of American Physicians. he is the recipient of the Pan American Society's Clinical Virology Award, the American Society for STD Research's Parran Award and the University of Michigan Medical School's Distinguished Alumnus Award. Dr. Corey is a recipient of multiple industry awards and most recently, was awarded the 2022 Alexander Fleming Award by the Infectious Diseases Society of America. He received his infectious diseases training at the University of Washington. Dr. Corey received his B.S. and M.D. from the University of Michigan and his infectious diseases training at the University of Washington.

公司職務